We are pleased to announce that Ryan Flannigan, a fellowship trained Male Infertility and Sexual Medicine expert will be returning to the UBC Faculty of Medicine as an Assistant Professor in the Department of Urologic Sciences, effective July 1, 2018. Dr. Flannigan was awarded a prestigious Translational Scientist Position in the Faculty of Medicine. Dr. Flannigan has spent 2 years in New York at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Centre working with pioneers in the field of male reproduction, Dr. Peter Schlegel, Dr. Marc Goldstein & Dr. Darius Paduch as well sexual medicine, Dr. John Mulhall. Prior to his sub-specialty training, Dr. Flannigan completed his Urology residency here at the University of British Columbia (2016), and his MD degree from the University of Calgary (2011).
Clinically, Dr. Flannigan’s practice will be specialized in male infertility and sexual medicine. Dr. Flannigan will evaluate men with all presentations of infertility, and utilize both medical and surgical management strategies. Dr. Flannigan will perform a full array of infertility procedures including: microsurgical varicocele repairs, microdissection testicular sperm extraction (microTESE), percutaneous sperm retrievals, electro ejaculation for men with spinal cord injuries and microsurgical vasectomy reversals including both the micro-dot vasovasostomy and vasoepididymostomy procedures, among others. Dr. Flannigan has also been trained in and weill perform no-scalpel vasectomies. Dr. Flannigan will also have a focus on the evaluation, medical and surgical treatment of men with Peyronies disease, erectile dysfunction, ejaculatory dysfunction and spinal cord injury associated infertility and sexual dysfunction. Dr. Flannigan performs penile implant surgery, Peyronies injections, Peyronies plications as well as excision and grafting techniques.
Dr. Flannigan will join the Department of Urologic Sciences as the Director of Male Reproduction and Sexual Medicine Research. Dr. Flannigan’s research program is focused on evaluating genetic and molecular mechanisms contributing to non-obstructive azoospermia (NOA), using precision single-cell strategies and in vitro methods, with the goal of identifying novel therapeutic targets to treat men with no presently available treatments. Dr. Flannigan also has a focused interest in investigating the molecular mechanisms contributing to Peyronies Disease with the goal to translate his results into novel therapeutic strategies. Beyond bench science, Dr. Flannigan is involved in numerous clinical trials and is actively involved in research related to preventative health and health promotion jointly with the Canadian Men’s Health Foundation.
You can find more information about Dr.Flannigan at his website :
Please welcome Dr. Flannigan back to the Department of Urologic Sciences, Faculty of Medicine, UBC.